Diabetes Clinical Trials in San Francisco

Showing 221-240 of 255 trials

Blood Sugar Take Care and Glucose Metabolism

NCT01554020

This prospective international clinical trial is a two-arm, double-blind, randomized, placebo-controlled, parallel-group, multicenter study. 112 prediabetic subjects will be randomized to Blood Sugar Take Care or placebo. Randomization will be stratified by gender. The intervention period is 12 weeks. The primary outcome is fasting glucose levels.

Prediabetes

NewChapter, Inc.Started Jun 2012

San Francisco, California, United States

COMPLETEDNA< 1 mile

Improving Diabetes Efforts Across Language and Literacy (IDEALL)

NCT00214474

The IDEALL Project (Improving Diabetes Efforts Across Language and Literacy) is a 3-arm randomized controlled trial to explore contextual factors at the patient, clinician, and organizational level of two patient self-management support strategies. A communication technology-based intervention (automated telephone diabetes management) and an interpersonally-oriented intervention (group medical visits)will be compared to usual care for their ability to improve diabetes outcomes among vulnerable populations in 4 safety-net health centers in the University of California, San Francisco (UCSF) Collaborative Research Network.

Diabetes

Agency for Healthcare Research and Quality (AHRQ)339 participantsStarted Nov 2002

San Francisco, California, United States

COMPLETEDPHASE2< 1 mile

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

NCT00476931

The purpose of the study is to study the clinical effects of the investigational drug, SB-509 versus placebo in patients with diabetic neuropathy.

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic Polyneuropathy

Sangamo Therapeutics91 participantsStarted May 2007

La Jolla, California, United States • Lakewood, California, United States • Lomita, California, United States +17 more locations

Blood Sugar Take Care and Glucose Metabolism

Improving Diabetes Efforts Across Language and Literacy (IDEALL)

Clinical Trial of SB-509 in Subjects With Diabetic Neuropathy

Diabetes Trials in Other Cities

Follow-Up Study for Exubera

A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes

A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes

A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione

Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes

Mechanisms of Glucose Lowering Effect of Colesevelam HCl

Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone

WelChol® and Insulin in Treating Patients With Type 2 Diabetes

Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment

A Study for Patients With Type 2 Diabetes Mellitus

Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles

Screening for Early Evidence of Diabetes

Testing the Developmental Origins Hypothesis

DPBRN Blood Sugar Testing in Dental Patients

GALLANT 6 Tesaglitazar vs. Pioglitazone

Other Conditions in San Francisco